CD8 expression in B-cell non-Hodgkin’s lymphomas

By Carulli Giovanni  

Annals of Hematology, Vol. 87, Iss. 7, 2008-07 ,pp. : 577-579

Springer Publishing Company

Access to resources Recommend Favorite

Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study

By Uppenkamp M.   Engert A.   Diehl V.   Bunjes D.   Huhn D.   Brittinger G.  

Annals of Hematology, Vol. 81, Iss. 1, 2002-01 ,pp. : 26-32

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of ifosfamide, etoposide, and oxaliplatin (IFETOx) chemotherapy for relapsed or refractory non-Hodgkin’s lymphoma

By Kim Seon-Kyeong   Song Moo-Kon   Chung Joo   Shin Ho-Jin  

International Journal of Hematology, Vol. 98, Iss. 5, 2013-11 ,pp. : 543-548

Springer Publishing Company

Access to resources Recommend Favorite

Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin’s lymphoma

By Hess Georg   Flohr Thomas   Kolbe Karin   Bonn Sarah   Schuler Martin   Derigs Hans   Huber Christoph  

Annals of Hematology, Vol. 85, Iss. 11, 2006-11 ,pp. : 769-779

Springer Publishing Company

Access to resources Recommend Favorite

TNF-α induces changes in LDH isotype profile following triggering of apoptosis in PBL of non-Hodgkin’s lymphomas

By Jurisic V.  

Annals of Hematology, Vol. 83, Iss. 2, 2004-02 ,pp. : 84-91

Springer Publishing Company

Access to resources Recommend Favorite